CTNND1 and neoplasm: The induction of an active tumor microenvironment in premalignant and invasive cancer lesions of DBPDE treated mice resemble that seen in a genetically engineered mouse model of oral cancer, the p120ctn knockout mouse with loss of p120ctn targeted to the oral cavity and esophagus [8].